tirzepatide crohn's disease Patients with stable inflammatory bowel (IBD) and comorbid obesity and/or diabetes who started GLP-1 receptor agonists (semaglutide or tirzepatide) alongside ongoing treatment did not have a lower risk for the relapse tirzepatide crohn's Mounjaro and Disease:

Concurrent medications

Patients who receive and consistently take the medication report results consistent with clinical trial data: 10 to 15% body weight loss over 6 to 12 months on semaglutide, and up to 20%+ on tirzepatide

The new approval reinforces Krazatis potential across tumor types, the company said in a press release

In November 2025, the Trump administration announced landmark agreements with Eli Lilly and Novo Nordisk reducing the monthly price of GLP-1 weight-loss drugs from over $1,000 to as low as $245 for eligible patients

Many pharmacies and hospitals accept full sharps containers at no charge

A deficiency in B12 can lead to fatigue, weakness, numbness, tingling sensations, and memory problems